Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 14, 2012

View Archived Issues

New therapeutic target identified for schizophrenia

Nanoparticles targeting microRNA inhibit lymphoma

Novo Nordisk announces highlights of second quarter 2012

MultiCell Technologies updates on candidate dsRNA anticancer therapies

Protalix BioTherapeutics to begin clinical testing of candidate Fabry's disease drug

Bionor Pharma to conduct HIV vaccine combination study

AspenBio Pharma submits pre-IDE package for appendicitis test

Biofrontera and Pelpharma Handels sign distribution agreement

Scientists in China isolate new saponins from bunge fruit

Canadian university patents novel melanocortin MC4 receptor modulators

Compounds for ADHD treatment synthesized in France

New glutamate receptor antagonists presented by Taisho Pharmaceutical

Novel calcium channel antagonists developed at U.S. university

Nagasaki University reports new candidate anticancer products

Meritage Pharma launches trial in eosinophilic esophagitis

Recruitment complete in first stage of TACTT1 study

FDA extends PDUFA action date for Gattex NDA

Novel HCV entry inhibitor selected for further evaluation

New E.U. approval for Votrient

Second-generation Shigella vaccines designed in U.S.

PDUFA date for Santarus NDA extended

Tarceva approved in Canada for specific NSCLC subtype

FDA accepts for filing Teva's NDA for new oral contraceptive

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...